Kandi KNDI Entry Point Kandi Technologies posts 002 EPS 1276M revenue Is Addus ADUS stock stable Addus HomeCare Corporation tops EPS estimates by narrow 06 percent margin What FuelCell Energy FCEL does that creates lasting value 414 20260507 The scenario planning at Santander CL BSAC Q4 2025 EPS Beats Forecasts How Lifetime Brands LCUT earnings track against industry trends Q1 2026 Profit Surprises Does Stellar V SVCC stock offer a good entry point SVCC Latest Quarter Earnings Stellar V withholds core financials shares see sharp trading swings What is happening with Elbit Systems ESLT stock today Smart Money Active 20260420 CalMaine CALM Stock 13D Filings 162 20260420 Bayer CropScience Q4 Net Profit Rises 13 to 162 Crore on Revenue Growth Lowes LOW Gains Positive Mention from Jim Cramer Amid Market Skepticism Analyst Coverage Update Viatris Incs Market Outlook Under Review Apple Inc AAPLs Strengthening Growth Narrative Highlights Services and Ecosystem Expansion ADP Private Payrolls Rising 109000 in April Surpass Expectations Signaling a Resilient Labor Market Trump Indicates Iran Deal and Strait of Hormuz Reopening Near Agreement agilon health Q1 2026 Earnings Massive EPS Beat Drives Stock Surge YUMC Q1 2026 Earnings EPS Miss and Cautious Outlook Weigh on Shares HSIC Q1 2026 Earnings Strong EPS Beat Amid Solid Operational Performance BCRX Q1 2026 Earnings EPS Misses Estimates Stock Rises on Operational Updates CDLX Q1 2026 Earnings Adjusted Loss Narrows EPS Surprise of 4945 Beats Expectations GECC Q1 2026 Earnings EPS Beats Estimates by 126 Amid Stable Operations TryHard Holdings THH Jumps 74 Testing Key Resistance at 038 LPCVU Holds Steady Near 10 as SPAC Unit Trades in Tight Range Trinity Capital Inc TRIN Holds Steady Near Support as Trading Volume Remains Subdued NTRSO Preferred Shares Hold Steady Near 1870 as Support Levels Tested Beeline Holdings BLNE Falls 63 as Stock Tests Support Near 120 Perpetua Resources Secures 29 Billion US Loan for Idaho GoldAntimony Project Amid Critical Mineral Push SLGL Q4 2025 Earnings EPS Misses Estimates as DevelopmentStage Biotech Reports No Revenue Corcept Therapeutics CORT Rallies Sharply Pushing Toward Resistance at 69